Skip to main content

Table 3 Comparisons between patients with IMV and non-IMV (Median, IQR)

From: Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers

 

Non-intubated group

n = 5

IMV group

n = 5

P value

Male(n,%)

4 (80%)

2 (40%)

0.003*

Age (year)

42 (30–49)

17 (16–33)

0.032*

APACHEII

6 (4–12)

17 (11–21)

0.028*

PaO2/FiO2

230 (159–262)

96 (51–158)

0.032*

Lactate

0.9 (0.7–1.3)

1.3 (1.2–1.7)

0.056

Breathing rate (breaths/min)

26 (25–31)

27 (23–29)

0.690

Tmax((°C))

40 (39.5–41.3)

40 (39.7–40.9)

0.841

Procalcitonin

0.175 (0.14–0.195)

1.05 (0.45–2.09)

0.016*

White blood cell count(109/L)

4.5 (3.8–7.3)

7.6 (5.5–8.7)

0.151

Neutrophil proportion(%)

73 (54–82)

92 (83–94)

0.016*

AST (U/L)

81 (33–102)

100 (41–121)

0.548

Albumin (g/L)

29 (28–34)

32 (26–39)

1.0

Pre-albumin (g/L)

0.08 (0.02–0.15)

0.03 (0.03–0.04)

0.571

Creatine (umol/L)

55 (47–69)

43 (35–76)

1.0

C-reactive protein (CRP, mg/L)

17 (6–48)

93 (11–209)

0.286

Erythrocyte sedimentation rate (ESR,mm/h)

25 (5.5–28.5)

12 (4–25)

0.675

Length of onset to ICU admission (days)

11 (9.5–14)

14 (7.5–15)

0.421

Length of ICU stay (days)

4 (3–18.5)

13 (17.5–23.5)

0.056

  1. APACHE II Acute physiological and chronic health evaluation II score; *P < 0.05